Market Definition
The blood bank center is where blood is stored and preserved to use in blood transfusion for the patients suffering from the deficiency of blood or blood components. Organ Banks helps to recover, storage, process, and distributing of organ, body tissue and bone for transplantation. Organ and tissue donation can save lives which marks the importance of blood and organ banks.
Market Dynamics
Rising prevalence of hematological diseases is a key driving factor of the market. Hematological diseases are pathological conditions affecting the blood and blood-producing organs. Hematologic disorders involve the blood and problems with red blood cells, white blood cells, bone marrow, lymph nodes, platelets, and spleen. Hemotherapy is a therapeutic method that uses blood and other blood components in order to treat hematological diseases. The various processes in hemotherapy are controlled by the blood bank. According to the National Institutes of Health (NIH), Hematologic afflict millions of Americans. An estimate of 178,520 people in the US are expected to be diagnosed with leukemia, myeloma and lymphoma in 2020. According to the World Health Organization (WHO), around 5% of the world's population carries trait genes for hemoglobin disorders, such as sickle-cell disease and thalassaemia. Thalassemia affects 4.4 of every 10,000 live births throughout the world. According to the World Health Organization (WHO), globally, anaemia affects 1.62 billion people, which is 24.8% of the population. However, postoperative complications for transplantation of organs and transfusion of blood might hamper the market growth. Blood transfusion increases the risk of postoperative complications such as infections, respiratory complications, cytomegalovirus infection, graft failure. In some life-threatening blood transfusion, postoperative complications include acute kidney failure, anemia and shock (lack of adequate blood flow). Moreover, organ transplantation and blood transfusion in emerging nations would provide lucrative opportunities for the market in the coming years.
Market Segmentation
The global blood and organ bank market is mainly classified based on product and service and end user. Product and Service are further segmented into Blood Plasma Collection, Processing and Distribution Services, Red Blood Cell Collection, Processing and Distribution Services, Tissue Bank Services, Organ Bank Services, Health screening services, and Others. By end user, the market is divided into Hospitals, Blood Banks, Diagnostic Centres, and Others.
Red Blood Cell Collection, Processing and Distribution Services was dominating the blood and organ bank market in 2019, owing to the partnership between organizations and companies for supply and research of red blood cell. For instance, ERYTECH Pharma has partnered with New York Blood Center (NYBC) for red blood cell supply and research. With this partnership NYBC becoming a long-term supplier of donor red blood cells (RBC) to ERYTECH, that enabling ERYTECH to diversify and broaden its supply of RBC for the production of eryaspase and future product candidates derived from its proprietary ERYCAPS platform as the company ramps up clinical development for the Phase 3 trial in second-line metastatic pancreatic cancer in Europe, and the Phase 2 trial in triple-negative breast cancer (TNBC) in the United States early in 2019.
Regional Analysis
Based on geography, the global blood and organ bank market is divided into North America, Europe, Asia-Pacific, South America, and Middle East & Africa. North America is further divided in the U.S., Canada, and Mexico, whereas Europe consists of the UK, Germany, France, Italy, and Rest of Europe. Asia-Pacific is segmented into India, China, Japan, South Korea, and Rest of Asia-Pacific. The South America region includes Brazil, Argentina, and the Rest of South America, while the Middle East & Africa is categorized into GCC Countries, Egypt, South Africa, and Rest of Middle East & Africa.
North America was dominating the blood and organ bank market in 2019, due to the government support for creating awareness for blood donation and restoring donors, increasing number of accidents rise the demand for blood or organ and raising funds for improving organ transportation, tracking, and logistics services. For instance, The Fresenius Medical Care Foundation has donated $106,000 to the United Network for Organ Sharing (UNOS), to help improve transportation and logistics for organ donation. Fresenius Medical Care North America (FMCNA), will help to predict organ travel time better and improve tracking using biosensor technology to ensure fewer kidneys are discarded due to time.
Competitive landscape
Key players operating in the blood and organ bank industry include New England Donor Services, New York Blood Centre, American Red Cross, 21st Century Medicine, National Cord Blood Program, Musculoskeletal Transplant Foundation, National Organ and Tissue Transplant Organisation, The Living Bank, Cord Blood Registry, and China Cord Blood Corporation.
Increasing awareness for blood donation and organ donation by companies and government, increasing commercialization of service related to blood and organ bank, and partnership between companies and organization to provide blood and organ donation services are some of the strategies adopted by the major companies. For instance, OneLegacy, the organ, eye and tissue recovery organization in the nation, has entered into a community partnership with LifeStream Blood Bank, providers of blood products and services to hospitals. The partnership is designed to provide call attention to the connection between organ and blood donation.
Blood and Organ Bank Market Key Segments:
By Product and Service
- Blood Plasma Collection, Processing and Distribution Services
- Red Blood Cell Collection, Processing and Distribution Services
- Tissue Bank Services
- Organ Bank Services
- Health screening services
- Others
By End User
- Hospitals
- Blood Banks
- Diagnostic Centres
- Others
Key Global Blood and Organ Bank Industry Players
- New England Donor Services
- New York Blood Centre
- American Red Cross
- 21st Century Medicine
- National Cord Blood Program
- Musculoskeletal Transplant Foundation
- National Organ and Tissue Transplant Organisation
- The Living Bank
- Cord Blood Registry
- China Cord Blood Corporation
What Report Provides
- Full in-depth analysis of the parent Industry
- Important changes in market and its dynamics
- Segmentation details of the market
- Former, on-going, and projected market analysis in terms of volume and value
- Assessment of niche industry developments
- Market share analysis
- Key strategies of major players
- Emerging segments and regional growth potential
